342 related articles for article (PubMed ID: 35029907)
1. Consensus recommendations on managing the selected comorbidities including cardiovascular disease, osteoporosis, and interstitial lung disease in rheumatoid arthritis.
Yu KH; Chen HH; Cheng TT; Jan YJ; Weng MY; Lin YJ; Chen HA; Cheng JT; Huang KY; Li KJ; Su YJ; Leong PY; Tsai WC; Lan JL; Chen DY
Medicine (Baltimore); 2022 Jan; 101(1):e28501. PubMed ID: 35029907
[TBL] [Abstract][Full Text] [Related]
2. [Expert consensus on the management of interstitial lung disease during the COVID-19 epidemic].
Respiratory Council of Chinese Research Hospital Association
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Dec; 46(12):1204-1218. PubMed ID: 38044048
[TBL] [Abstract][Full Text] [Related]
3. Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative.
Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Siu S; Kraft J; Lynde C; Pope J; Gulliver W; Keeling S; Dutz J; Bessette L; Bissonnette R; Haraoui B
J Rheumatol; 2015 Oct; 42(10):1767-80. PubMed ID: 26178281
[TBL] [Abstract][Full Text] [Related]
4. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update.
Agca R; Heslinga SC; Rollefstad S; Heslinga M; McInnes IB; Peters MJ; Kvien TK; Dougados M; Radner H; Atzeni F; Primdahl J; Södergren A; Wallberg Jonsson S; van Rompay J; Zabalan C; Pedersen TR; Jacobsson L; de Vlam K; Gonzalez-Gay MA; Semb AG; Kitas GD; Smulders YM; Szekanecz Z; Sattar N; Symmons DP; Nurmohamed MT
Ann Rheum Dis; 2017 Jan; 76(1):17-28. PubMed ID: 27697765
[TBL] [Abstract][Full Text] [Related]
5. Screening for rheumatoid arthritis-associated interstitial lung disease-a Delphi-based consensus statement.
Hackner K; Hütter L; Flick H; Grohs M; Kastrati K; Kiener H; Lang D; Mosheimer-Feistritzer B; Prosch H; Rath E; Schindler O; Moazedi-Fürst F
Z Rheumatol; 2024 Mar; 83(2):160-168. PubMed ID: 38240817
[TBL] [Abstract][Full Text] [Related]
6. A retrospective study on the predictive implications of clinical characteristics and therapeutic management in patients with rheumatoid arthritis-associated interstitial lung disease.
Li L; Liu R; Zhang Y; Zhou J; Li Y; Xu Y; Gao S; Zheng Y
Clin Rheumatol; 2020 May; 39(5):1457-1470. PubMed ID: 31858341
[TBL] [Abstract][Full Text] [Related]
7. Consensus statement on a framework for the management of comorbidity and extra-articular manifestations in rheumatoid arthritis.
Loza E; Lajas C; Andreu JL; Balsa A; González-Álvaro I; Illera O; Jover JÁ; Mateo I; Orte J; Rivera J; Rodríguez Heredia JM; Romero F; Martínez-López JA; Ortiz AM; Toledano E; Villaverde V; Carmona L; Castañeda S
Rheumatol Int; 2015 Mar; 35(3):445-58. PubMed ID: 25543267
[TBL] [Abstract][Full Text] [Related]
8. Assessment of interstitial lung disease among black rheumatoid arthritis patients.
McFarlane IM; Zhaz SY; Bhamra MS; Burza A; Kolla S; Alvarez MR; Koci K; Taklalsingh N; Pathiparampil J; Freeman L; Kaplan I; Kabani N; Ozeri DJ; Watler E; Frefer M; Vaitkus V; Matthew K; Arroyo-Mercado F; Lyo H; Zrodlowski T; Feoktistov A; Sanchez R; Sorrento C; Soliman F; Valdez FR; Dronamraju V; Trevisonno M; Grant C; Clerger G; Amin K; Dawkins M; Green J; Moon J; Fahmy S; Waite SA
Clin Rheumatol; 2019 Dec; 38(12):3413-3424. PubMed ID: 31471819
[TBL] [Abstract][Full Text] [Related]
9. The Design and Rationale of the Trail1 Trial: A Randomized Double-Blind Phase 2 Clinical Trial of Pirfenidone in Rheumatoid Arthritis-Associated Interstitial Lung Disease.
Solomon JJ; Danoff SK; Goldberg HJ; Woodhead F; Kolb M; Chambers DC; DiFranco D; Spino C; Haynes-Harp S; Hurwitz S; Peters EB; Dellaripa PF; Rosas IO;
Adv Ther; 2019 Nov; 36(11):3279-3287. PubMed ID: 31515704
[TBL] [Abstract][Full Text] [Related]
10. Kuwait association of rheumatology 2018 treatment recommendations for patients with rheumatoid arthritis.
Alhajeri H; Abutiban F; Al-Adsani W; Al-Awadhi A; Aldei A; AlEnizi A; Alhadhood N; Al-Herz A; Alkandari W; Dehrab A; Muhanna Ghanem AA; Hasan E; Hayat S; Saleh K; Tarakmeh H; Ali Y
Rheumatol Int; 2019 Sep; 39(9):1483-1497. PubMed ID: 31309293
[TBL] [Abstract][Full Text] [Related]
11. Management issues in rheumatoid arthritis-associated interstitial lung disease.
England BR; Hershberger D
Curr Opin Rheumatol; 2020 May; 32(3):255-263. PubMed ID: 32141954
[TBL] [Abstract][Full Text] [Related]
12. Rheumatoid arthritis related interstitial lung disease.
Manfredi A; Cassone G; Luppi F; Atienza-Mateo B; Cavazza A; Sverzellati N; González-Gay MA; Salvarani C; Sebastiani M
Expert Rev Clin Immunol; 2021 May; 17(5):485-497. PubMed ID: 33779447
[TBL] [Abstract][Full Text] [Related]
13. Openreuma Consensus on the role of nursing in the care of patients with rheumatoid arthritis and diffuse interstitial lung disease.
Cano García L; García de Yébenes MJ; Vázquez NM; Martín Martín JM; Domínguez Quesada C; García-Díaz S; Rodríguez Vargas AI; de la Torre-Aboki J; Jiménez Núñez F; Espíldora Hernández F; León Mateos L; Vázquez Lojo A; Marcos Pérez E; Castiblanco L; Carmona L
Invest Educ Enferm; 2022 Oct; 40(3):. PubMed ID: 36867790
[TBL] [Abstract][Full Text] [Related]
14. Rheumatoid arthritis-associated interstitial lung disease: an overview of epidemiology, pathogenesis and management.
Dai Y; Wang W; Yu Y; Hu S
Clin Rheumatol; 2021 Apr; 40(4):1211-1220. PubMed ID: 32794076
[TBL] [Abstract][Full Text] [Related]
15. Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study.
Kelly CA; Saravanan V; Nisar M; Arthanari S; Woodhead FA; Price-Forbes AN; Dawson J; Sathi N; Ahmad Y; Koduri G; Young A;
Rheumatology (Oxford); 2014 Sep; 53(9):1676-82. PubMed ID: 24758887
[TBL] [Abstract][Full Text] [Related]
16. The challenging interplay between rheumatoid arthritis, ageing and comorbidities.
van Onna M; Boonen A
BMC Musculoskelet Disord; 2016 Apr; 17():184. PubMed ID: 27118031
[TBL] [Abstract][Full Text] [Related]
17. SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 1: Epidemiology, risk factors and prognosis.
Rodríguez Portal JA; Brito García N; Díaz Del Campo Fontecha P; Valenzuela C; Ortiz AM; Nieto MA; Mena-Vázquez N; Cano-Jiménez E; Castellví I; Aburto M; Bonilla G; Hernández Hernández MV; Francisco Hernández FM; Correyero Plaza M; Castrejón I; Abad Hernández MÁ; Narváez J
Reumatol Clin (Engl Ed); 2022 Oct; 18(8):443-452. PubMed ID: 36085196
[TBL] [Abstract][Full Text] [Related]
18. Analysis of risk factors of mortality in rheumatoid arthritis patients with interstitial lung disease: a nationwide, population-based cohort study in Taiwan.
Ng KH; Chen DY; Lin CH; Chao WC; Chen HH
RMD Open; 2022 Aug; 8(2):. PubMed ID: 35995491
[TBL] [Abstract][Full Text] [Related]
19. High-resolution computed tomography of the lung in patients with rheumatoid arthritis: Prevalence of interstitial lung disease involvement and determinants of abnormalities.
Salaffi F; Carotti M; Di Carlo M; Tardella M; Giovagnoni A
Medicine (Baltimore); 2019 Sep; 98(38):e17088. PubMed ID: 31567944
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with sarcopenia in Japanese patients with rheumatoid arthritis: results from the IORRA cohort study.
Nakayama M; Furuya T; Inoue E; Tanaka E; Ikari K; Yamanaka H; Harigai M
Clin Rheumatol; 2024 Jan; 43(1):521-526. PubMed ID: 37731082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
